Pluvia attracts interest from new governmental seed funding
Sarsia Seed recently announced their new seed funds in Bergen consisting of 300 million NOK. Initial investment can be in the biotechnology company Pluvia founded by Prof. Aurora Martinez according to Sarsia officials.
Main content
The announcement was first published on the front page of e24.no:
http://e24.no/naeringsliv/gr-nder/staten-starter-saakornfond-dette-kan-b...
Bergens Tidende followed up on:
http://www.bt.no/nyheter/lokalt/Martinez-krysser-fingrene-for-sakornfond...
The company Pluvia was established based on research headed by Prof. Aurora Martinez on the development of a new therapeutic option for phenylketonuria. The researchers in Biorecogintion group has discovered a small molecule compound with the ability to bind and stabilize mutant variants of phenylalanine hydroxylase and thereby rescue its activity.
- Pluvia is a spin-off company from research in the Biorecognition group at the Department of Biomedicine, UiB.
- Promising new therapeutic options for phenylketonuria (Føllings disease) has attracted the attention from investors.
- A new seed funds consisting of 300 million NOK managed by Sarisa Seed AS was announced Friday last week (March 24 2017).
